Close

Arcturus Therapeutics (ARCT) Completes Merger with Alcobra (ADHD) and Commences Trading on Nasdaq Global Market

November 16, 2017 7:13 AM EST Send to a Friend
Arcturus Therapeutics Ltd. (Nasdaq: ARCT), a leading RNA medicines company, announced today the completion of its previously announced merger with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login